Experienced in Non-Small Cell Lung Cancer (NSCLC)

Dr. Irene F. Connolly

Hematology Oncology | Palliative Medicine | Hematology
Mclaren Central Michigan
1221 S Dr, 
Mt Pleasant, MI 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Non-Small Cell Lung Cancer (NSCLC)
Mclaren Central Michigan
1221 S Dr, 
Mt Pleasant, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Irene Connolly is a Hematologist Oncology specialist and a Palliative Medicine provider in Mt Pleasant, Michigan. Dr. Connolly is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Bone Marrow Aspiration. Dr. Connolly is currently accepting new patients.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 2 clinical trials in the study of Non-Small Cell Lung Cancer (NSCLC).

Specialties
Hematology Oncology
Palliative Medicine
Hematology
Licenses
Internal Medicine in MI
Hospital Affiliations
Mclaren Northern Michigan
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

MCLAREN CENTRAL MICHIGAN
1221 S Dr, Mt Pleasant, MI 48858
Other Locations
MCLAREN CENTRAL MICHIGAN
560 W Mitchell St, Suite C70, Petoskey, MI 49770

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Study to Assess the Ability to Initiate Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Patients Based on Genomic Analyses of Tumor Specimens.
A Study to Assess the Ability to Initiate Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Patients Based on Genomic Analyses of Tumor Specimens.
Enrollment Status: Recruiting
Publish Date: July 25, 2025
Intervention Type: Other
Study Phase: Not Applicable
Phase I Study of Thoracic Radiotherapy and Concurrent Chemotherapy With Soy Isoflavones in Stage III NSCLC (Non-Small Cell Lung Cancer) Patients
Phase I Study of Thoracic Radiotherapy and Concurrent Chemotherapy With Soy Isoflavones in Stage III NSCLC (Non-Small Cell Lung Cancer) Patients
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug, Dietary supplement, Radiation
Study Phase: Phase 1
Targeting the Prostatic Tumor Microenvironment With PLX3397, a Tumor-Associated Macrophage Inhibitor in Men With Unfavorable Risk Prostate Cancer Undergoing Radiation Therapy and Androgen Deprivation Therapy
Targeting the Prostatic Tumor Microenvironment With PLX3397, a Tumor-Associated Macrophage Inhibitor in Men With Unfavorable Risk Prostate Cancer Undergoing Radiation Therapy and Androgen Deprivation Therapy
Enrollment Status: Completed
Publish Date: October 06, 2020
Intervention Type: Drug, Other, Radiation
Study Phase: Phase 1
View 2 Less Clinical Trial

2 Total Publications

A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer.
A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer.
Journal: Advances in radiation oncology
Published: November 17, 2020
Similar Doctors
Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Salah M. Almokadem
Hematology Oncology | Hematology | Oncology
Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Salah M. Almokadem
Hematology Oncology | Hematology | Oncology

Newaygo County General Hospital Association

230 W Oak St, Corewell Health Gerber Hos, 
Fremont, MI 
 (60.3 miles away)
231-924-1305
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Salah Almokadem is a Hematologist Oncology specialist and a Hematologist in Fremont, Michigan. Dr. Almokadem is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma.

Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Muhammad Y. Hamdan
Hematology Oncology | Oncology | Hematology
Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Muhammad Y. Hamdan
Hematology Oncology | Oncology | Hematology

Sparrow Ionia Hospital

3565 S State Rd, 
Ionia, MI 
 (48.4 miles away)
616-523-1600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Muhammad Hamdan is a Hematologist Oncology specialist and an Oncologist in Ionia, Michigan. Dr. Hamdan is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Hamdan is currently accepting new patients.

Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Gordon Srkalovic
Hematology Oncology | Hematology | Oncology
Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Gordon Srkalovic
Hematology Oncology | Hematology | Oncology

Edward W Sparrow Hospital Association

1140 E Michigan Ave, 
Lansing, MI 
 (60.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gordon Srkalovic is a Hematologist Oncology specialist and a Hematologist in Lansing, Michigan. Dr. Srkalovic is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Castleman Disease, Lung Cancer, Pleuropulmonary Blastoma, and Lymphoid Hyperplasia. Dr. Srkalovic is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Connolly's expertise for a condition
ConditionClose
      View All 20 Advanced Conditions
      View All 121 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile